← Open Payments lookup

TAYLOR MARTINUZZI: Open Payments

NPI 1144930041 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$549 in 33 payments from 8 companies in 2025. Trend: 2023 $785 · 2024 $945 · 2025 $549

Food & beverage: $549
CompanyPaymentsAmount
Novo Nordisk Inc13$210
Lilly USA, LLC9$147
Janssen Pharmaceuticals, Inc3$54
Amgen Inc.3$48
PFIZER INC.2$43
Merck Sharp & Dohme LLC1$20
GlaxoSmithKline, LLC.1$15
Kowa Pharmaceuticals America, Inc.1$14

Products named: MOUNJARO, Wegovy, SPRAVATO, Rybelsus, EVENITY, ELIQUIS, CAPVAXIVE, OTEZLA.

Industry payments across TX — which companies pay providers there.